Project: AD Shield – presymptomatic Alzheimer’s disease detection & prevention of citizens at high risk
| Acronym | AD Shield (Reference Number: 12748) |
| Duration | 01/04/2019 - 02/04/2021 |
| Project Topic | The project will refine and validate two breakthrough innovations for early detection of Alzheimer’s disease (AD) and AD prevention and combine them into a one-stop digital medical device. The first innovation is a highly sensitive cognitive assessment method that can detect cognitive decline of presymptomatic AD. The second is artificial intelligence controlled neurogames. The ambition is to create and become the global standard of care for both presymptomatic AD detection and prevention. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 10 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Brain+ ApS | Coordinator | Denmark |
| 2 | Aarhus University | Partner | Denmark |
| 3 | Research Institutes of Sweden, Interactive Institute AB | Partner | Sweden |
| 4 | Lytics Health AB | Partner | Sweden |
| 5 | Aarhus University Hospital | Partner | Denmark |